Mesenchymal Stem Cells in the Treatment of Burn Wounds
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe First Affiliated Hospital of Xinxiang Medical College
About this trial
Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.
Eligibility criteria
Qualifiers
Voluntary participation and signing of the informed consent form;
Burn patients, subjects requiring autologous skin grafting;
Age 18 to 65 years old, gender not restricted;
During this clinical study, single person, single donor skin area (lateral thigh or trunk) treatment;
Disqualifiers
Those allergic to sodium alginate (gel component);
Electric shock injuries, chemical burns, radiation injuries or combined with other traumas;
Subjects with severe systemic diseases (judged by the researchers);
Subjects with uncontrolled hypertension or diabetes (judged by the researchers);
Trial design
Treatments tested in this trial
- low-dose stem cell gel group
- high-dose stem cell gel group
- with only the gel
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov